Thomas Pfisterer - Jun 17, 2024 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Role: Director
Signature: Lisa Kallebo, as Attorney-in-Fact for Thomas Pfisterer
Stock symbol: ADCT
Transactions as of: Jun 17, 2024
Transactions value $: -$4,153
Form type: 4
Date filed: 6/18/2024, 09:38 PM
Previous filing: Jun 14, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADCT	Common Shares	Sale	-$4.15K	-1.44K	-0.67%	$2.89	214K	Jun 17, 2024	Direct	F1
holding	ADCT	Common Shares						452K	Jun 17, 2024	By HPWH TH AG	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Common Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units.
F2	The reporting person disclaims beneficial ownership of all Common Shares held of record by HPWH TH AG ("HPWH"), other than the Common Shares in HPWH that are indirectly represented by the reporting person's 41.7% interest in HPWH MH AG, which owns a 12.5% interest in HPWH, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the remaining Common Shares in HPWH for purposes of Section 16 or for any other purpose.

Content

Represents Common Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units.

The reporting person disclaims beneficial ownership of all Common Shares held of record by HPWH TH AG ("HPWH"), other than the Common Shares in HPWH that are indirectly represented by the reporting person's 41.7% interest in HPWH MH AG, which owns a 12.5% interest in HPWH, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the remaining Common Shares in HPWH for purposes of Section 16 or for any other purpose.